Procept Biorobotics Share Price Today
(NASDAQ: PRCT)

Name: Procept Biorobotics Share Price Today (NASDAQ: PRCT) - Procept Biorobotics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Procept Biorobotics share price is $72.5 & ₹6,281.40 as on 1 Feb 2025, 2.30 'hrs' IST

$72.5

▲

0.93

(1.3%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Procept Biorobotics share price in Dollar and Rupees. Guide to invest in Procept Biorobotics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Procept Biorobotics, along with analyst recommendations, forecasts, and comprehensive financials.

Procept Biorobotics share price movements

Today's Low: $71.41
Today's High: $73.93
$72.50
1.51%
Downside
Day's Volatility :3.42%
Upside
1.93%
52 Weeks Low: $45.20
52 Weeks High: $103.81
$72.50
37.66%
Downside
52 Weeks Volatility :56.46%
Upside
30.16%

Procept Biorobotics (PRCT) Returns

Period	Procept Biorobotics	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.31%	-0.6%	0.0%
6 Months	28.75%	-2.8%	0.0%
1 Year	51.33%	3.3%	0.0%
3 Years	277.02%	11.6%	-13.7%

Procept Biorobotics (PRCT) Key Statistics

in dollars & INR

Previous Close	$71.57
Open	$71.69
Today's High	$73.9299
Today's Low	$71.405
Market Capitalization	$3.9B
Today's Volume	$524.1K
52 Week High	$103.8099
52 Week Low	$45.2
Revenue TTM	$199.8M
EBITDA	$-101.4M
Earnings Per Share (EPS)	$-1.95
Profit Margin	-50.07%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.02%

How to invest in Procept Biorobotics Stock (PRCT) from India?

It is very easy for Indian residents to invest directly in Procept Biorobotics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Procept Biorobotics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Procept Biorobotics or PRCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Procept Biorobotics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Procept Biorobotics shares which would translate to 0.012 fractional shares of Procept Biorobotics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Procept Biorobotics, in just a few clicks!

Returns in Procept Biorobotics (PRCT) for Indian investors in Rupees

The Procept Biorobotics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Procept Biorobotics investment value today

Current value as on today

₹1,55,885

Returns

₹55,885

(+55.88%)

Returns from Procept Biorobotics Stock

₹51,325 (+51.33%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Procept Biorobotics (PRCT)

-2%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Procept Biorobotics Stock from India on INDmoney has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Procept Biorobotics

FMR Inc
13.48%
Vanguard Group Inc
8.95%
BlackRock Inc
6.74%
AllianceBernstein L.P.
2.84%
Loomis, Sayles & Company LP
2.30%
State Street Corp
2.18%

Analyst Recommendation on Procept Biorobotics

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Procept Biorobotics(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Procept Biorobotics Stock (PRCT)

What analysts predicted

Upside of 41.72%

Target:

$102.75

Current:

$72.50

Insights on Procept Biorobotics Stock (Ticker Symbol: PRCT)

Price Movement
In the last 3 years, PRCT stock has moved up by 282.4%
Increasing Revenue
Revenue is up for the last 18 quarters, 1.19M → 58.37M (in $), with an average increase of 19.0% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -27.50M → -20.97M (in $), with an average increase of 9.8% per quarter
PRCT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 57.9% return, outperforming this stock by 4.9%
Price to Sales
ForPRCT every $1 of sales, investors are willing to pay $18.6, whereas for Boston Scientific Corp., the investors are paying $9.5 for every $1 of sales.

PRCT Procept Biorobotics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$6.2M	-
Net Income	$-42.7M	-
Net Profit Margin	-691.41%	-

	FY20	Y/Y Change
Revenue	$7.7M	↑ 25.09%
Net Income	$-58.3M	↑ 36.58%
Net Profit Margin	-754.89%	↓ 63.48%

	FY21	Y/Y Change
Revenue	$34.5M	↑ 346.72%
Net Income	$-62.4M	↑ 7.09%
Net Profit Margin	-180.96%	↑ 573.93%

	FY22	Y/Y Change
Revenue	$75.0M	↑ 117.6%
Net Income	$-93.6M	↑ 50.01%
Net Profit Margin	-124.76%	↑ 56.2%

	FY23	Y/Y Change
Revenue	$136.2M	↑ 81.55%
Net Income	$-105.9M	↑ 13.16%
Net Profit Margin	-77.76%	↑ 47.0%

	Q2 FY23	Q/Q Change
Revenue	$33.1M	↑ 35.65%
Net Income	$-25.3M	↓ 8.73%
Net Profit Margin	-76.38%	↑ 37.15%

	Q3 FY23	Q/Q Change
Revenue	$35.1M	↑ 6.04%
Net Income	$-24.6M	↓ 2.62%
Net Profit Margin	-70.14%	↑ 6.24%

	Q4 FY23	Q/Q Change
Revenue	$43.6M	↑ 24.16%
Net Income	$-27.5M	↑ 11.7%
Net Profit Margin	-63.11%	↑ 7.03%

	Q1 FY24	Q/Q Change
Revenue	$44.5M	↑ 2.2%
Net Income	$-26.0M	↓ 5.62%
Net Profit Margin	-58.28%	↑ 4.83%

	Q2 FY24	Q/Q Change
Revenue	$53.4M	↑ 19.79%
Net Income	$-25.6M	↓ 1.28%
Net Profit Margin	-48.03%	↑ 10.25%

	Q3 FY24	Q/Q Change
Revenue	$58.4M	↑ 9.4%
Net Income	$-21.0M	↓ 18.15%
Net Profit Margin	-35.93%	↑ 12.1%

	FY19	Y/Y Change
Profit	$-1.9M	-

	FY20	Y/Y Change
Profit	$-1.3M	↓ 33.42%

	FY21	Y/Y Change
Profit	$15.9M	↓ 1364.14%

	FY22	Y/Y Change
Profit	$37.1M	↑ 133.75%

	FY23	Y/Y Change
Profit	$71.0M	↑ 91.58%

	Q2 FY23	Q/Q Change
Profit	$18.4M	↑ 47.54%

	Q3 FY23	Q/Q Change
Profit	$18.9M	↑ 2.41%

	Q4 FY23	Q/Q Change
Profit	$19.9M	↑ 5.63%

	Q1 FY24	Q/Q Change
Profit	$25.0M	↑ 25.57%

	Q2 FY24	Q/Q Change
Profit	$30.2M	↑ 20.69%

	Q3 FY24	Q/Q Change
Profit	$36.9M	↑ 22.17%

	FY19	Y/Y Change
Operating Cash Flow	$-43.8M	-
Investing Cash Flow	$43.2M	-
Financing Cash Flow	$26.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 10.33%
Investing Cash Flow	$-233.0K	↓ 100.54%
Financing Cash Flow	$106.8M	↑ 302.5%

	FY21	Y/Y Change
Operating Cash Flow	$-57.3M	↑ 18.6%
Investing Cash Flow	$-592.0K	↑ 154.08%
Financing Cash Flow	$262.1M	↑ 145.49%

	FY22	Y/Y Change
Operating Cash Flow	$-80.4M	↑ 40.2%
Investing Cash Flow	$-2.7M	↑ 348.14%
Financing Cash Flow	$3.6M	↓ 98.62%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-28.3M	↓ 21.12%
Investing Cash Flow	$-5.4M	↑ 0.62%
Financing Cash Flow	$2.4M	↑ 539.47%

Procept Biorobotics Technicals Summary

Sell

Neutral

Buy

Procept Biorobotics is currently in a neutral trading position according to technical analysis indicators.

Procept Biorobotics (PRCT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procept Biorobotics	-12.82%	28.75%	51.33%	277.02%	72.87%
Medtronic Plc	13.21%	13.06%	3.64%	-12.14%	-23.03%
Edwards Lifesciences Corp.	-0.19%	19.36%	-15.84%	-35.79%	-1.17%
Boston Scientific Corp.	14.52%	40.3%	59.02%	147.01%	142.39%
Stryker Corporation	9.08%	23.85%	14.4%	53.77%	84.88%
Abbott Laboratories	12.77%	17.77%	14.11%	-1.62%	46.94%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Procept Biorobotics	53.06	NA	NA	-1.75	-0.37	-0.17	NA	4.63
Medtronic Plc	28.13	28.13	1.56	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	28.3	28.3	6.72	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	85.16	85.16	1.86	2.46	0.09	0.05	NA	14.05
Stryker Corporation	50.25	50.25	2.73	13.51	0.19	0.07	0.01	52.86
Abbott Laboratories	16.74	16.74	2.32	5.15	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procept Biorobotics	Buy	$3.9B	72.87%	53.06	-50.07%
Medtronic Plc	Buy	$118.0B	-23.03%	28.13	12.06%
Edwards Lifesciences Corp.	Buy	$43.2B	-1.17%	28.3	65.86%
Boston Scientific Corp.	Buy	$151.9B	142.39%	85.16	11.26%
Stryker Corporation	Buy	$148.8B	84.88%	50.25	16.34%
Abbott Laboratories	Buy	$221.9B	46.94%	16.74	13.99%

About Procept Biorobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Organization	Procept Biorobotics
Employees	626
CEO	Dr. Reza Zadno Ph.D.
Industry	Healthcare

Management People of Procept Biorobotics

Name	Title
Dr. Reza Zadno Ph.D.	President, CEO & Director
Mr. Kevin Waters	Executive VP & CFO
Ms. Alaleh Nouri	EVP, Chief Legal Officer & Corporate Secretary
Mr. Hisham Shiblaq	Executive VP & Chief Commercial Officer
Mr. Mohan F. Sancheti	Senior Vice President of Operations
Mr. Barry Templin	Executive VP of Technology & Clinical Development
Mr. Matthew James Bacso C.F.A.	Vice President of Investor Relations
Ms. Stacey L. Porter	Chief People Officer
Mr. Bijesh Chandran	Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in PRCT Stock from India :

What is Procept Biorobotics share price today?

Procept Biorobotics share price today stands at $72.50, Open: $71.69 ; Previous Close: $71.57 ; High: $73.93 ; Low: $71.41 ; 52 Week High: $103.81 ; 52 Week Low: $45.20.

The stock opens at $71.69, after a previous close of $71.57. The stock reached a daily high of $73.93 and a low of $71.41, with a 52-week high of $103.81 and a 52-week low of $45.20.

Can Indians buy Procept Biorobotics shares?

Yes, Indians can invest in the Procept Biorobotics (PRCT) from India.

With INDmoney, you can buy Procept Biorobotics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Procept Biorobotics at zero transaction cost.

How can I buy Procept Biorobotics shares from India?

It is very easy to buy Procept Biorobotics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Procept Biorobotics (PRCT) be purchased?

Yes, you can buy fractional shares of Procept Biorobotics with INDmoney app.

What are the documents required to start investing in Procept Biorobotics stocks?

To start investing in Procept Biorobotics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.